Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies specific for hyperphosphorlated tau for the treatment of ocular diseases

Antibodies specific for hyperphosphorlated tau for the treatment of ocular diseases

US Patent 10995137 · Granted May 4, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies specific for hyperphosphorylated tau and methods of use thereof2024
Antibodies specific for hyperphosphorylated tau and methods of use thereof2024
Antibodies specific for hyperphosphorylated tau and methods of use thereof2024
Antibodies specific for hyperphosphorylated tau and methods of use thereof2024
Antibodies specific for hyperphosphorylated tau and methods of use thereof2024
Antibodies specific for hyperphosphorylated tau and methods of use thereof2023
Antibodies specific for hyperphosphorylated tau and methods of use thereof2023
Antibodies specific for hyperphosphorylated tau and methods of use thereof2023
Antibodies specific for hyperphosphorylated tau and methods of use thereof2023
Antibodies specific for hyperphosphorylated tau and methods of use thereof2023
Antibodies specific for hyperphosphorylated tau and methods of use thereof2021
Antibodies specific for hyperphosphorylated tau and methods of use thereof2021